Key figures of the Group 20221 20231 2024 20251
Business
Sales EUR million 4,618 4,730 4,999 4,929
Organic sales growth in % 11.4 7.9 8.7 2.8
EBITDA EUR million 922 903 1,033 1,081
EBITDA margin in % 20.0 19.1 20.7 21.9
EBIT EUR million 630 611 718 782
EBIT margin in % 13.6 12.9 14.4 15.9
Net income EUR million 406 340 478 513
Business free cash flow EUR million 301 553 680 780
Investments (without M&A) EUR million 270 270 231 214
Balance sheet total (as of December 31) EUR million 7,783 7,846 8,325 7,904
Capital ratio (as of December 31) in % 46.4 47.0 48.3 47.3
Net debt (incl. pension provisions and similar obligations
(as of December 31))
EUR million 2,692 2,666 2,343 2,088
Research and development expenses EUR million 254 266 276 276
Employees (not including trainees and apprentices) at December 31 12,043 12,435 12,718 12,745
Capital market
Shares issued as of balance sheet date millions 139.8 139.8 139.8 139.8
Share price at end of fiscal year (Xetra® closing price) in EUR 101.7 99.6 102.7 68.88
Market capitalization at end of fiscal year EUR million 14,208 13,927 14,350 9,628
Earnings per share in EUR 2.91 2.44 3.42 3.67
Dividend per share in EUR 1.05 1.10 1.20 1.252
Footprint (environment)
Change in eco-efficiency of greenhouse gas emissions (Scope 1+2)3 in % -10.4 -4.4 -9.4 7.9
Change in absolute greenhouse gas emissions (Scope 3) in % -6.6 -2.4 15.3 40.6
Change in eco-efficiency of chemical oxygen demand in wastewater3 in % -11.2 -10.7 -3.3 -8.7
Change in eco-efficiency of hazardous waste3 in % -3.8 6.3 -3.0 5.8
Water use (at production sites in regions with water stress
(= Egypt, India, Mexico, Spain, Chile))
in % -4.3 -30.9 15.0 -4.0
Innovation
Sales with new product developments in % 15.1 15.0 15.0 12.5
Sourcing (procurement)
Suppliers rated according to sustainability criteria in % 874 1005 1005 1005
Sustainable sourcing of strategic biological raw materials in % 88 95 92 90
Care (employees)
Women in the first management level in % 16 14 23 26
Women in the second management level in % 37 38 44 43
Accident frequency MAQ6 2.8 2.3 1.5 1.2
1
Key figures are adjusted for one-time effects; further details of the individual indicators are contained in the chapter "Alternative performance indicators".
2
Proposal
3
All figures relative to the value added
4
Based on 80% (until 2021) or 90% (from 2022) of the procurement volume
5
Based on the German Supply Chain Due Diligence Act (LkSG), all active suppliers were subjected to a risk assessment
6
MAQ = work accidents (>1 lost day) x 1 million/working hours; industry-leading occupational safety as of 2025
CEO interview
The ONE SYM change program is already proving successful: portfolio adjustments, measures to improve efficiency and organizational improvements strengthen competitiveness in a sustainable manner. An interview with CEO Dr Jean‑Yves Parisot.
Learn more
Group figures 2025
A look at the numbers shows how Symrise has evolved in the 2025 fiscal year.
Learn more
Financial calendar
An overview of upcoming dates and events for investors for 2026, as well as all the important financial presentations, are listed here.
Learn more
Editorial
The Editorial of the Executive Board sets out how Symrise is advancing its strategic transformation to strengthen competitiveness and grow sustainably.
Learn more
Close
Fullscreen
Loading …